Versartis Inc (NASDAQ:VSAR)

21.43
Delayed Data
As of Mar 05
 +0.03 / +0.14%
Today’s Change
16.15
Today|||52-Week Range
36.86
-4.54%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$624.8M

Company Description

Versartis, Inc. is an endocrine-focused biopharmaceutical company. It develops long-acting therapeutic proteins for the treatment of endocrine disorders. The company develops new therapeutic proteins utilizing the novel half-life extension technology XTEN. Versartis was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Redwood City, CA.

Contact Information

Versartis, Inc.
275 Shoreline Drive
Redwood City California 94065
P:(650) 963-8580
Investor Relations:
(212) 213-0006

Employees

Shareholders

Individual stakeholders40.35%
Other institutional26.84%
Mutual fund holders20.94%

Top Executives

Jeffrey L. ClelandPresident, Chief Executive Officer & Director
Joshua T. BrummChief Financial Officer
Eric HumphrissVice President-Clinical Operations
Paul B. WestbergSenior Vice President-Business Development
Patrick M. MurphyVice President-Manufacturing

To view my watchlist

Not a member yet?

Sign up now for a free account